Q4 2024 · 13F-HR/A
Birchview Capital, LPholdings as filed
Filed 2025-06-30 · accession 0001618205-25-000008
$122.9M
Reported value
68
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $38.8M | 31.5% | 685,182 | Common | SOLE |
| 09075X108 | — | BIODESIX INC | $8.8M | 7.14% | 5,736,113 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $6.2M | 5.05% | 338,400 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $4.6M | 3.73% | 1,225,489 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $4.2M | 3.43% | 304,574 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $4.1M | 3.36% | 30,240 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $3.7M | 3.03% | 74,000 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $3.5M | 2.87% | 10,000 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $3.2M | 2.64% | 197,000 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $3.2M | 2.64% | 764,062 | Common | SOLE |
| 74838J101 | — | QUIDELORTHO CORP | $3.0M | 2.45% | 67,619 | Common | SOLE |
| 71944F106 | PHR | PHREESIA INC | $2.9M | 2.35% | 114,700 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $2.6M | 2.10% | 148,000 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $2.5M | 2.06% | 15,280 | Common | SOLE |
| 415858109 | HROW | HARROW HEALTH INC | $2.4M | 1.99% | 72,910 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.3M | 1.88% | 210,000 | Common | SOLE |
| 69047Q102 | OVV | OVINTIV INC | $2.1M | 1.72% | 52,200 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $2.1M | 1.69% | 78,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $1.9M | 1.51% | 48,000 | Common | SOLE |
| 26884L109 | EQT | EQT CORPORATION | $1.6M | 1.30% | 34,619 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $1.5M | 1.19% | 310,930 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.4M | 1.17% | 50,000 | Common | SOLE |
| 89455T109 | TMCI | TREACE MEDICAL CONCEPTS INC | $1.2M | 0.98% | 161,350 | Common | SOLE |
| G6674U108 | NVCR | NOVOCURE LTD | $923,800 | 0.75% | 31,000 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $718,000 | 0.58% | 50,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $673,120 | 0.55% | 16,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $597,480 | 0.49% | 26,000 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $593,400 | 0.48% | 30,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $567,490 | 0.46% | 67,000 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $532,440 | 0.43% | 58,000 | Common | SOLE |
| 137404109 | CADL | CANDEL THERAPEUTICS INC | $520,800 | 0.42% | 60,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $494,800 | 0.40% | 40,000 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $494,494 | 0.40% | 32,110 | Common | SOLE |
| 40637H109 | HALO | HALOZYME THERAPEUTICS INC | $478,100 | 0.39% | 10,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $470,400 | 0.38% | 10,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $446,740 | 0.36% | 14,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $425,565 | 0.35% | 3,500 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MEDICAL INC | $409,330 | 0.33% | 368,766 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $392,000 | 0.32% | 10,000 | Common | SOLE |
| 00430H102 | — | ACCELERATE DIAGNOSTICS INC | $390,287 | 0.32% | 325,239 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $377,500 | 0.31% | 125,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $361,300 | 0.29% | 10,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $353,200 | 0.29% | 20,000 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $346,290 | 0.28% | 51,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HOLDING CORP | $345,760 | 0.28% | 8,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $338,440 | 0.28% | 4,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $300,800 | 0.24% | 40,000 | Common | SOLE |
| 046513206 | ATRA | ATARA BIOTHERAPEUTICS INC | $292,820 | 0.24% | 22,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $287,550 | 0.23% | 15,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $283,932 | 0.23% | 419,832 | Common | SOLE |
| G11196105 | — | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $275,083 | 0.22% | 7,365 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $263,760 | 0.21% | 28,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $243,600 | 0.20% | 20,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $237,450 | 0.19% | 15,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $235,494 | 0.19% | 2,700 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $216,600 | 0.18% | 4,000 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $135,135 | 0.11% | 16,500 | Common | SOLE |
| 25459W102 | TECL | DIREXION DAILY PHARMACEUTICAL & MEDICAL BULL 3X SH | $127,800 | 0.10% | 18,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $124,994 | 0.10% | 138,176 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $123,500 | 0.10% | 50,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $117,600 | 0.10% | 10,000 | Common | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $113,160 | 0.09% | 82,000 | Common | SOLE |
| 641288105 | NPCE | NEUROPACE INC | $111,900 | 0.09% | 10,000 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $78,600 | 0.06% | 10,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $63,072 | 0.05% | 28,800 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $51,510 | 0.04% | 17,000 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $46,549 | 0.04% | 15,833 | Common | SOLE |
| 71902K105 | — | CERO THERAPEUTICS HOLDINGS INC | $778 | 0.00% | 12,972 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.